SCHEMBL21641920

SCHEMBL21641920

CCc1ccc(OC)c(S(=O)(=O)N(Cc2ccc(OC)cc2OC)c2noc3ccc(CNC(C)=O)cc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ MAPT P10636 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MTNR1A P48039 2/20 0.36
▸ MTNR1B P49286 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ KAT7 O95251 2/20 0.35
▸ KAT6B Q8WYB5 2/20 0.35
▸ KAT6A Q92794 2/20 0.35
▸ KAT5 Q92993 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21641916 0.95 KMT2A (0.39) KMT2APOLBMAPTMEN1ALDH1A1
SCHEMBL21596842 0.89 KAT7 (0.36) POLBMAPTALDH1A1TP53TSHR
SCHEMBL31605563 0.89 KAT7 (0.36) POLBMAPTALDH1A1TP53TSHR
SCHEMBL21596820 0.88 TDP1 (0.38) KMT2APOLBMAPTMEN1RAB9A
SCHEMBL30838426 0.87 KAT7 (0.36) POLBMAPTTP53KAT7KAT6B
SCHEMBL21596783 0.87 KAT7 (0.36) POLBMAPTTP53KAT7KAT6B
SCHEMBL21596814 0.87 ALDH1A1 (0.42) KMT2APOLBMAPTMEN1ALDH1A1
SCHEMBL21596794 0.86 MAPT (0.37) KMT2APOLBMAPTMEN1TP53
SCHEMBL31605548 0.86 MAPT (0.37) KMT2APOLBMAPTMEN1TP53
SCHEMBL21596780 0.86 MAPT (0.36) KMT2APOLBMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 — — EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 — — EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 — — US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 KMT2A 4165/4885POLB 3605/4885MAPT 1135/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 KMT2A 4165/4885POLB 3604/4885MAPT 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback